Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Anticancer Research
|
January 31, 2012
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy
Frank Richardson, G David Young, Regina Sennello, et al.
Cancer Research
|
August 3, 2007
Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102
Barbara Sennino, Beverly L Falcón, Dilara McCauley, et al.
Cancer Research
|
March 3, 2011
Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors
Beverly L Falcon, Sharon Barr, Prafulla C Gokhale, et al.
International Journal of Cardiology
|
August 21, 2007
Costs of an early intervention versus a conservative strategy in acute coronary syndrome
David M Epstein, Mark J Sculpher, Tim C Clayton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 2020
A tumor-associated splice-isoform of <i>MAP2K7</i> drives dedifferentiation in MBNL1-low cancers via JNK activation
Debleena Ray, Yu Chye Yun, Muhammad Idris, et al.
Cancer Research
|
October 17, 2020
The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition
Jia Yu, Permeen A Mohamed Yusoff, Daniëlle T J Woutersen, et al.
International Journal of Technology Assessment in Health Care
|
May 6, 2006
Randomized trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: cost-effectiveness analysis
Andrea Manca, David M Epstein, David J Torgerson, et al.
Cells, Tissues, Organs
|
November 3, 2010
Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models
Gretchen M Argast, Peter Mercado, Iain J Mulford, et al.
Journal of Cellular Physiology
|
January 19, 2006
Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies
Hideo Akiyama, Shu Kachi, Raquel Lima E Silva, et al.
Clinical & Experimental Metastasis
|
January 4, 2011
A systems view of epithelial-mesenchymal transition signaling states
Stuart Thomson, Filippo Petti, Izabela Sujka-Kwok, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Anticancer Research
|
January 31, 2012
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy
Frank Richardson, G David Young, Regina Sennello, et al.
Cancer Research
|
August 3, 2007
Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102
Barbara Sennino, Beverly L Falcón, Dilara McCauley, et al.
Cancer Research
|
March 3, 2011
Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors
Beverly L Falcon, Sharon Barr, Prafulla C Gokhale, et al.
International Journal of Cardiology
|
August 21, 2007
Costs of an early intervention versus a conservative strategy in acute coronary syndrome
David M Epstein, Mark J Sculpher, Tim C Clayton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 2020
A tumor-associated splice-isoform of <i>MAP2K7</i> drives dedifferentiation in MBNL1-low cancers via JNK activation
Debleena Ray, Yu Chye Yun, Muhammad Idris, et al.
Cancer Research
|
October 17, 2020
The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition
Jia Yu, Permeen A Mohamed Yusoff, Daniëlle T J Woutersen, et al.
International Journal of Technology Assessment in Health Care
|
May 6, 2006
Randomized trial of a brief physiotherapy intervention compared with usual physiotherapy for neck pain patients: cost-effectiveness analysis
Andrea Manca, David M Epstein, David J Torgerson, et al.
Cells, Tissues, Organs
|
November 3, 2010
Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models
Gretchen M Argast, Peter Mercado, Iain J Mulford, et al.
Journal of Cellular Physiology
|
January 19, 2006
Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies
Hideo Akiyama, Shu Kachi, Raquel Lima E Silva, et al.
Clinical & Experimental Metastasis
|
January 4, 2011
A systems view of epithelial-mesenchymal transition signaling states
Stuart Thomson, Filippo Petti, Izabela Sujka-Kwok, et al.
Page
of 4